Medifast (MED) Tops Q1 EPS by 23c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.49 -1.11%
Revenue Growth %: -24.3%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -24.3%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q1 EPS of $1.56, $0.23 better than the analyst estimate of $1.33. Revenue for the quarter came in at $178.5 million versus the consensus estimate of $165.71 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Morgan Stanley upgrades Synopsys as it turns selective on chip stocks
- HSBC Raises S&P500 Target to 8,100
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
